Mollan, MBChB, FRCOphth, professor and neuro-ophthalmology consultant at the University of Birmingham, United Kingdom, wrote an invited commentary on the study in the same issue of JAMA Ophthalmology
The Russian peptide-bioregulator school established by Khavinson has produced a family of related short peptides
Compounded Semaglutide hasn't been widely used yet but offers potential benefits through customization based on patient needs i.e., dosage adjustments could be made according to individual patients' tolerance and response rate
Its meant for a very small group of patients, not mass distribution, says Reshma Ramachandran, MD, an assistant professor at Yale School of Medicine and co-director of the Yale Collaboration for Regulatory Rigor, Integrity, and Transparency